Information de reference pour ce titreAccession Number: | 00136308-200611000-00016.
|
Author: | Moro, Elena +1; Lang, Anthony E 2
|
Institution: | (1)Assistant Professor of Neurology, University of Toronto, Department of Medicine, Movement Disorders Center, 399 Bathurst Street, McL7 402, Canada. (2)University of Toronto, Department of Medicine, Movement Disorders Center, 399 Bathurst Street, McL7 402, Canada.
|
Title: | Criteria for deep-brain stimulation in Parkinson's disease: review and analysis.[Review]
|
Source: | Expert Review of Neurotherapeutics. 6(11):1695-1705, November 2006.
|
Abstract: | : Deep-brain stimulation is currently the most effective surgical treatment for advanced Parkinson's disease. The relevant targets to date are the subthalamic nucleus and the globus pallidus internus, although the thalamus (ventralis intermedius nucleus) is preferred in tremor-dominant, aged Parkinson's disease patients. Long-term benefit in cardinal parkinsonian signs, motor fluctuations and dyskinesia has been reported in 5-year follow-up studies of subthalamic nucleus deep-brain stimulation. However, some psychiatric consequences have raised important issues and emphasized the need for an experienced deep-brain stimulation surgical team. This team should be multidisciplinary and involve movement disorder neurologists, neurosurgeons, neuropsychologists and psychiatrists. The recent observation that deep-brain stimulation of the pedunculopontine nucleus improves axial signs, possibly even in those less responsive to levodopa, brings new hope to the management of advanced Parkinson's disease.
(C) 2006Expert Reviews, Ltd.
|
Author Keywords: | deep-brain stimulation; globus pallidus; movement disorders; neurostimulation; pallidotomy; Parkinson's disease; subthalamic nucleus; thalamotomy.
|
References: | 1 Bower JH, Maraganore DM, McDonnel SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 52, 1214-1220 (1999).
2 De Rijk MC, Breteler MMB, Graveland GA. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurological Disease in the Elderly Research Group. Neurology 54, S21-S23 (2000).
3 Lang AE, Lozano AM. Parkinson's disease. First of two parts. N. Engl. J. Med. 339, 1044-1053 (1998).
4 Clayton DF, George JM. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21, 249-254 (1998).
5 Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318, 121-134 (2004).
6 Feldman RG, Ratner MH. The pathogenesis of neurodegenerative disease: neurotoxic mechanisms of action and genetics. Curr. Opin. Neurol. 12, 725-731 (1999).
7 Zhang Y, Dawson VL, Dawson TM. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7, 240-250 (2000).
8 Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog. Brain Res. 85, 119-146 (1990). ** Extensive overview of the pathophysiology of Parkinson's disease (PD).
9 Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. 20, 91-127 (1995).
10 Middleton FA, Strick PL. Basal ganglia and cerebellar loop: motor and cognitive circuits. Brain Res. 31, 236-250 (2000).
11 Temel Y, Blokland A, Steinbush HWM, Visser-Vanderwalle V. The functional role of the subthalamic nucleus in cognitive and limbic circuits. Progress. Neurobiol. 76, 393-413 (2005). ** Extensive overview about the role of the subthalamic nucleus (STN).
12 Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375 (1989). ** Extensive overview of the pathophysiology of the basal ganglia.
13 Miller WC, DeLong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. The Basal Ganglia II. Carpenter MB, Jayaraman A (Eds). Plenum Press, NY, USA 415-427 (1987).
14 Smith Y, Bevan MD, Shink E, Bolam JP. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86, 353-387 (2000).
15 Levy R, Hutchison WD, Lozano AM, Dostrovsky JO. High frequency synchronization of neuronal activity in the subthlamic nucleus of parkinsonian patients with tremor. J. Neurosci. 20, 7766-7775 (2000).
16 Marsden JF, Limousin-Dowsey P, Ashby P, Pollak P, Brown P. Subthalamic nucleus, sensorimotor cortex and muscle interrelationship in Parkinson's disease. Brain 124, 378-388 (2001).
17 Lang AE, Obeso JA. Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease. Ann. Neurol. 55, 761-765 (2004). * Synopsis about what has been done so far in the treatment of PD and what should be done now.
18 Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson's disease. Arch. Neurol. 62, 1377-1381 (2005).
19 Lozano AM, Lang AE. Pallidotomy for Parkinson's disease. Neurosurg. Clin. N. Am. 9, 325-336 (1998).
20 Benabid AL, Pollak P, Gervason C et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337, 403-406 (1991).
21 Benazzoz A, Gross C, Feger J et al. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci. 5, 382-389 (1993).
22 Pollak P, Benabid AL, Gross C et al. Effects of the stimulation of the subthalamic nucleus in Parkinson's disease. Rev. Neurol. (Paris) 149, 175-176 (1993).
23 Sigfried J, Lippitz B. Bilateral chronic electrostimulation of the ventroposterolateral pallidum: a new therapeutic approach for alleviating parkinsonian symptoms. Neurosurg. 35, 1126-1130 (1994).
24 Kumar R, Lozano AM, Kim YJ et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 51(3), 850-855 (1998).
25 Ostergaard K, Sunde N, Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov. Disord. 17, 693-700 (2002).
26 Krack P, Batir A, Van Blercom N et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 349(20), 1925-1934 (2003). ** First report on the long-term follow-up (5 years) of STN stimulation in 49 consecutive patients with PD.
27 Pahwa R, Wilkinson SB, Overman J, Lyons KE. Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow-up. J. Neurosurg. 99, 71-77 (2003).
28 Rodriguez-Oroz MC, Obeso JA, Lang AE et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 128, 2240-2249 (2005). ** Report on the long-term follow-up (3-4 years) of a multicenter trial on STN and pallidal stimulation in advanced PD.
29 Schupbach WMM, Chastan N, Welter ML et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5-year follow up. J. Neurol. Neurosurg. Psychiatr. 76, 1640-1644 (2005).
30 Dostrovsky JO, Lozano AM. Mechanisms of deep brain stimulation. Mov. Disord. 17(Suppl. 3), S63-S68 (2002).
31 Houeto JL, Damier P, Bejjani PB et al. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch. Neurol. 57(4), 461-465 (2000).
32 Pollak P, Benabid AL, Krack P et al. Deep brain stimulation. In: Parkinson's Disease and Movement Disorder (3rd Edition). Jankovich J, Tolosa E (Eds). Williams & Wilkins, MD, USA, 1085-1101 (1998).
33 Charles PD, Van Blercom N, Krack P et al. Predictors of effective bilateral subthalamic nucleus stimulation for Parkinson's disease. Neurology 59(6), 932-934 (2002).
34 Welter ML, Houeto JL, Tezenas de Montcel S et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 125, 575-583 (2002).
35 Lang AE, Widner H. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov. Disord. 17(Suppl. 3), S94-S101 (2002).
36 Defer GL, Widner H, Marie RM, and the Conference participants. Core Assessment Program for Surgical Interventional Therapies in Parkinson's disease (CAPSIT-PD). Mov. Disord. 14, 572-584 (1999).
37 Lang AE, Houeto JL, Krack P et al. Deep brain stimulation: preoperative issues. Mov. Disord. 21(Suppl. 14), S171-S196 (2006).
38 Voon V, Saint-Cyr JA, Lozano AM, Moro E, Poon YY, Lang AE. Psychiatric symptoms in patients with Parkinson's disease presenting for deep stimulation surgery. J. Neurosurg. 103, 246-251 (2005).
39 Berney A, Vingerhoets F, Perrin A et al. Effect on mood of subthalamic deep brain stimulation (DBS) for Parkinson's disease: a consecutive series of 24 patients. Neurology 59, 1427-1429 (2002).
40 Okun MS, Fernandez HH, Pedraza O et al. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology 63, 161-163 (2004). * Report of a useful preliminary screening for parkinsonian candidates for stimulation.
41 Okun MS, Tagliati M, Porfar M et al. Management of referred deep brain stimulation failure. Arch. Neurol. 62, 1250-1255 (2005).
42 Deep Brain Stimulation for Parkinson's Disease. Lang AE, Deuschl G, Rezai AR (Eds). Mov. Disord. 21(Suppl. 14) (2006). ** Extensive literature-based guidelines for deep-brain stimulation in PD.
43 Goodman RR, Kim B, McClelland S et al. Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 77, 12-17 (2006).
44 Gironell A, Kulisevsky J, Rami L, Fortuny N, Garcia-Sanchez C, Pascual-Sedano B. Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study. J. Neurol. 250, 917-923 (2003).
45 Russman H, Ghika J, Villemure JG et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology 63, 1952-1954 (2004).
46 Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE. Long-term follow-up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J. Neurosurg. 99, 489-495 (2003).
47 Kleiner-Fisman G, Herzog J, Fisman DN et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord. (Suppl. 14), S290-S304 (2006).
48 Ondo W, Jankovich J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson disease tremor. Neurology 51, 1063-1069 (1998).
49 Chou KL, Forman MS, Trojanoski JQ, Hurtig HI, Baltuch GH. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case Report. J. Neurosurg. 100, 553-556 (2004).
50 Lyons KE, Wilkinson SB, Overman J, Pahwa R. Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology 63(4), 612-616 (2004).
51 Hamani C, Richter E, Schwalb JM, Lozano AM. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery 56, 1313-1321 (2005).
52 Hilker R, Portman AT, Voges J et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psychiatry 76, 1217-1221 (2005).
53 Krack P, Pollak P, Limousin P et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 121(Pt 3), 451-457 (1998).
54 Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 123, 2091-2108 (2000).
55 Meissner W, Schreiter D, Volkmann J et al. Deep brain stimulation in late-stage Parkinson's disease: a retrospective cost analysis in Germany. J. Neurol. 252, 218-223 (2005).
56 Bejjani BP, Gervais D, Arnuf I et al. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psychiatry 68, 595-600 (2000).
57 Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson's disease. Arch. Neurol. 62, 554-560 (2005).
58 Lagrange E, Krack P, Moro E et al. Bilateral subthalamic nucleus stimulation improves all aspects of health-related quality of life in Parkinson's disease. Neurology 59, 1976-1978 (2002).
59 Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep brain stimulation for Parkinson's disease. N. Engl. J. Med. 355, 896-908 (2006).
60 Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Recent Developments in Parkinson's Disease. Fahn S, Marsden CD, Goldstein M (Eds). Macmillan Health Care Information, NJ, USA (1987).
61 Molinuevo JL, Vallderiola F, Tolosa E et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch. Neurol. 57, 983-988 (2000).
62 Valldeoriola F, Pileri M, Tolosa E, Molinuevo JL, Rumia J, Ferrer E. Bilateral subthalamic stimulation monotherapy in advanced Parkinosn's disease: long-term follow-up of patients. Mov. Disord. 17, 125-132 (2002).
63 Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic deep brain stimulation replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 58(3), 396-401 (2002).
64 Pawha R, Wilkinson SB, Overman J, Lyon KE. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact. Funct. Neurosurg. 83, 80-83 (2005).
65 Visser-Vandewalle V, Temel Y, Colle H, van der Linden C. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy-parkinsonism. Report of four cases. J. Neurosurg. 98, 882-887 (2003).
66 Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet 350, 1675 (1997).
67 Capelle HH, Simpson RK, Kronnenbuerger M, Michaelson J, Tronnier V, Krauss JK. Long-term deep brain stimulation in elderly patients with cardiac pacemaker. J. Neurosurg. 102, 53-59 (2005).
68 Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirement in Parkinson's disease. Neurology 53, 85-90 (1999).
69 Setiawa M, Kraft S, Doig K et al. Referrals for movement disorder surgery: under-representation of females and reasons for refusal. Can. J. Neurol. Sci. 33, 53-57 (2006).
70 Morrison CE, Borod JC, Perrine K et al. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch. Clin. Neurospychol. 19, 165-181 (2004).
71 Hariz MI, Johansson F, Shamsgovara P, Johansson E, Hariz GM, Fagerlund M. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study. Mov. Disord. 15, 136-139 (2000).
72 Trepanier LL, Kumar R, Lozano AM, Lang AE, Saint-Cyr JA. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain Cogn. 42, 324-347 (2000).
73 Allegret M, Junque C, Valldeoriola F et al. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson's disease. Arch. Neurol. 58, 1223-1227 (2001).
74 Houeto JL, Mesnage V, Mallet L et al. Behavioral disorders, Parkinson's disease and subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psychiatry 72, 701-707 (2002).
75 Levy G, Jacobs DM, Tang MX et al. Memory and executive function impairment predict dementia in Parkinson's disease. Mov. Disord. 17, 1221-1226 (2002).
76 Caparros-Lefebvre D, Blond S, Pecheux N, Pasquier F, Petit H. Neuropsychological evaluation before and after thalamic stimulation in 9 patients with Parkinson's disease. Rev. Neurol. 148, 117-122 (1992).
77 Troster AI, Fields JA, Wilkinson SB et al. Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology 49, 1078-1083 (1997).
78 Loher TJ, Gutbrod K, Fravi NL, Pohle T, Burgunder JM, Krauss JK. Thalamic stimulation for tremor. Subtle changes in episodic memory are related to stimulation per se and not to a microthalamotomy effect. J. Neurol. 250, 707-713 (2003).
79 Ardouin C, Pillon B, Peiffer E et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann. Neurol. 46, 217-223 (1999).
80 Pillon B, Ardouin C, Damier P et al. Neuropsychological changes between 'off' and 'on' STN or GPi stimulation in Parkinson's disease. Neurology 55, 411-418 (2000).
81 Daniele A, Albanese A, Contarino MF et al. Cognitive and behavioral effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 74, 175-182 (2003).
82 Funkiewiez A, Ardouin C, Caputo E et al. Long-term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behavior in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 75, 834-839 (2004).
83 Hershey T, Revilla FJ, Wernle A, Gibson PS, Dowling JL, Perlmutter JS. Stimulation of STN impairs aspects of cognitive control in Parkinson's disease. Neurology 62, 1110-1114 (2004).
84 Vingerhoets G, van der Linden C, Lannoo E et al. Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 66, 297-304 (1999).
85 Volkmann J, Allert N, Voges J, Weiss PH, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced Parkinson's disease. Neurology 56, 548-551 (2001).
86 Burkhard PR, Vingerhoets FJ, Berney A et al. Suicide after successful deep brain stimulation for movement disorders. Neurology 63, 2170-2172 (2004).
87 Voon V, Moro E, Saint-Cyr JA, Lozano AM, Lang AE. Psychiatric symptoms following surgery for Parkinson's disease with an emphasis on subthalamic nucleus stimulation. In: Advances in Neurology (Volume 96). Behavioral Neurology of Movement Disorders. Anderson KE, Weiner WJ, Lang AE (Eds). Lippincott Williams and Wilkins, PA, USA, 130-147 (2005).
88 Witjas T, Baunez C, Henry JM et al. Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation. Mov. Disord. 20, 1052-1055 (2005).
89 Herzog J, Volkmann J, Krack P et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov. Disord. 18, 1332-1337 (2003).
90 Moro E, Esselink RA, Van Blercom N et al. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with previous unilateral pallidotomy and thalamotomy. Mov. Disord. 15, 753-755 (2000).
91 Fraix V, Pollak P, Moro E et al. Subthalamic nucleus stimulation in tremor-dominant patients with previous thalamic surgery. J. Neurol. Neuropsych. Psychiatry 76, 246-248 (2005).
92 Kleiner-Fisman G, Fisman DN, Zamir O et al. Subthalamic nucleus deep brain stimulation for Parkinson's disease after successful pallidotomy: clinical and electrophysiological observations. Mov. Disord. 19, 1209-1214 (2004).
93 Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann. Neurol. 55, 871-875 (2004).
94 Broggi G, Franzini A, Ferroli P et al. Effect of bilateral subthalamic electrical stimulation in Parkinson's disease. Surg. Neurol. 56, 89-94 (2001).
95 Peppe A, Pierantozzi M, Bassi A et al. Stimulation of the subthalamic nucleus compared to the globus pallidus internus in patients with Parkinson's disease. J. Neurosurg. 101, 195-200 (2004).
96 Hariz MI, Bergenheim AT. A comparative study on ventriculography and computerized tomography-guided determination of brain targets in functional stereotaxis. J. Neurosurg. 73, 565-571 (1990).
97 Starr PA. Placement of deep brain stimulators into the subthalamic nucleus or globus pallidus internus: technical approach. Stereotact. Funct. Neurosurg. 79, 18-145 (2002).
98 Simon SL, Douglas P, Batuch GH, Jaggi JL. Error analysis of MRI and Leksell stereotactic frame target localization in deep brain stimulation surgery. Stereotact. Funct. Neurosurg. 83, 1-5 (2005).
99 Cohen DS, Lustgarten JH, Miller E. Effects of coregistration of MR to CT images on MR stereotactic accuracy. J. Neurosurg. 82, 772-779 (1995).
100 Benazzouz A, Breit S, Koudsie A, Pollak P, Krack P, Benabid AL. Intraoperative microrecording of the subthalamic nucleus in Parkinson's disease. Mov. Disord. 17(Suppl. 3), S145-S149 (2002).
101 Hariz MI. Safety and risk of microelectrode recording in surgery for movement disorders. Stereotact. Funct. Neurosurg. 78, 146-157 (2002).
102 Pollak P, Krack P, Fraix V et al. Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease. Mov. Disord. 17(Suppl. 3), S155-S161 (2002).
103 Volkman J, Herzog J, Kopper F, Deuschl G. Introduction to the programming of deep brain stimulation. Mov. Disord. 17(Suppl. 3), S181-S187 (2002).
104 Dowsey-Limousin P. Post-operative management of Vim DBS for tremor. Mov. Disord. 17(Suppl. 3), S208-S211 (2002).
105 Krack P, Fraix V, Mendes A, Benabid AL, Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov. Disord. 17(Suppl. 3), S155-S161 (2002).
106 Kumar R. Methods for programming and patient management with deep brain stimulation of the globus pallidus for the treatment of advanced Parkinson's disease and dystonia. Mov. Disord. 17(Suppl. 3), S198-S207 (2002).
107 Moro E, Poon YY, Saint-Cyr JA, Lozano AM, Lang AE. Subthalamic nucleus stimulation: improvement in outcome with reprogramming. Arch. Neurol. 63, 1266-1272 (2006).
108 Grill WM. Safety consideration for deep brain stimulation: review and analysis. Exp. Rev. Med. Devices 2, 409-420 (2005).
109 Funkiewiez A, Ardouin C, Krack P et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov. Disord. 18, 524-530 (2003).
110 Mazzone P, Lozano AM, Stanzione P et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 16, 1877-1881 (2005).
111 Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 16, 1883-1887 (2005).
201 Medtronic medical technology www.medtronic.com
|
Language: | English.
|
Document Type: | Review.
|
Journal Subset: | Pharmacology.
|
ISSN: | 1473-7175
|
NLM Journal Code: | 101129944
|
DOI Number: | https://dx.doi.org/10.1586/14737...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|